Wellington Management Group LLP Ngm Biopharmaceuticals Inc Transaction History

Wellington Management Group LLP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $16,295 - $21,948	-1,180 Reduced 4.19%	27,005 $412,000
Q4 2021 Feb 11, 2022	BUY	$17.26 - $22.02 $486,473 - $620,633	28,185 New	28,185 $500,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.